Dr Lee Schwartzberg: There's Still an Education Gap for Biosimilars
November 19, 2019 – 
Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, discusses the importance of working with physicians to make sure they're comfortable prescribing biosimilars.
Dr Michael Kolodziej Weighs In on Paying for One-Time, Curative Therapies With High Price Tags
November 18, 2019 – 
Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc, on whether payers will get more comfortable paying for one-time, curative therapies with high price tags.
Vanessa Sammy on How New Data Tools Help Patients Choose a Site of Care
November 18, 2019 – 
New tools enabling data access can help patients choose the most appropriate site of care for their needs, representing a significant change in the care delivery paradigm, according to Vanessa Sammy, MPA, MHSA, senior director of commercial strategy and implementation for Remedy Partners.
Dr Melinda Magyari Discusses Data on Treating Pediatric MS
November 18, 2019 – 
Melinda Magyari, MD, PhD, consultant neurologist, the Danish Multiple Sclerosis Center, Copenhagen University Hospital, discusses the current body of data on treating pediatric multiple sclerosis (MS).
Dr David Snyder on When to Add Ruxolitinib to Treat GVHD
November 17, 2019 – 
Ruxolitinib should be added to treatment of patients with graft-versus-host disease (GVHD) are not improving on steroids or whose symptoms return after tapering, said David Snyder, MD, associate chair of the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope.
Nina Chavez on Whether Biosimilars Will Offer Cost Savings in Oncology
November 16, 2019 – 
Nina Chavez, MBA, FACMPE, chief operating officer, New Mexico Oncology Hematology Consultants, Ltd., discusses if she thinks biosimilars will play a role in lowering costs in coming years.
Aliza Ben-Zacharia: Understanding Cultural Backgrounds Key to Efficient Care for Patients with MS
November 15, 2019 – 
Understanding the cultural backgrounds and beliefs of patients with MS allows clinicians to provide effective care, said Aliza Ben-Zacharia, DNP, ANP, associate director at the Center for Nursing Research and Innovation at Mount Sinai.
Rhett Wilkerson Discusses Why Aligning a Patient's Treatment Plan and Financial Capacity Is Vital
November 14, 2019 – 
Providing patients with financial counseling related to their potential treatment costs alleviates financial burdens and promotes efficient care, said Rhett Wilkerson, BA, director of patient financial services dedicated to American Oncology Network at Florida Cancer Specialists & Research Institute.
Dr Prithviraj Bose on Treating Progression in Myelofibrosis
November 14, 2019 – 
Prithviraj Bose, MD, of MD Anderson Cancer Center discusses treatment options for patients progressing with myelofibrosis.
Dr James Hamrick on Challenges With Understanding, Acting on What Constitutes Value for Patients
November 13, 2019 – 
James Hamrick, MD, senior medical director at Flatiron Health, discusses some of the biggest challenges with trying to understand what constitutes value for patients and then turning that into actionable information.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.